Bryogen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 21-12-2024
- Paid Up Capital ₹ 1.50 M
as on 21-12-2024
- Company Age 14 Year, 22 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.22 Cr
as on 21-12-2024
- Revenue 32.34%
(FY 2022)
- Profit 21.63%
(FY 2022)
- Ebitda 22.39%
(FY 2022)
- Net Worth 21.24%
(FY 2022)
- Total Assets 7.04%
(FY 2022)
About Bryogen Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.22 Cr.
Rohit Tripathi and Manish Tripathi serve as directors at the Company.
- CIN/LLPIN
U24232HR2010PTC041648
- Company No.
041648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bryogen Pharmaceuticals?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rohit Tripathi | Director | 02-Dec-2010 | Current |
Manish Tripathi | Director | 08-Feb-2016 | Current |
Financial Performance of Bryogen Pharmaceuticals.
Bryogen Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.34% increase. The company also saw a substantial improvement in profitability, with a 21.63% increase in profit. The company's net worth Soared by an impressive increase of 21.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bryogen Pharmaceuticals?
Unlock access to Bryogen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Brainrootz Labs Private LimitedActive 9 years 2 months
Rohit Tripathi and Manish Tripathi are mutual person
- En Ligne Entreprise (India) Private LimitedActive 2 years 8 months
Rohit Tripathi and Manish Tripathi are mutual person
- Helios Cyber Security Research And Investigation CouncilActive 2 years 10 months
Rohit Tripathi and Manish Tripathi are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 27 Aug 2024 | ₹0.71 M | Open |
Hdfc Bank Limited Creation Date: 25 Apr 2024 | ₹1.21 M | Open |
Others Creation Date: 31 Jul 2018 | ₹1.03 Cr | Open |
How Many Employees Work at Bryogen Pharmaceuticals?
Unlock and access historical data on people associated with Bryogen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bryogen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bryogen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.